AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteDyphylline is a xanthine derivative with bronchodilator and vasodilator effects. It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.
More Information Supplier PageDyphylline is a xanthine derivative with bronchodilator and vasodilator effects. It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.
More Information Supplier PageDyphylline is a xanthine derivative with bronchodilator and vasodilator effects. It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.
More Information Supplier Page3 Deazaneplanocin A (DZNep) is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
More Information Supplier Page3 Deazaneplanocin A (DZNep) is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
More Information Supplier Page3 Deazaneplanocin A (DZNep) is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
More Information Supplier Page3 Deazaneplanocin A (DZNep) is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase.
More Information Supplier PageE-64d is an inhibitor of cathepsins B and L and it is lysosome and cell permeable.
More Information Supplier PageE-64d is an inhibitor of cathepsins B and L and it is lysosome and cell permeable.
More Information Supplier PageE-64d is an inhibitor of cathepsins B and L and it is lysosome and cell permeable.
More Information Supplier PageE-64d is an inhibitor of cathepsins B and L and it is lysosome and cell permeable.
More Information Supplier PageE-3810 is a potent and selective dual inhibitor of VEGF and FGF receptors with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM and 82.5 nM for VEGFR-1, VEGFR-2, VEGFR-3, FGFR-1 and FGFR-2, respectively.
More Information Supplier PageE-3810 is a potent and selective dual inhibitor of VEGF and FGF receptors with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM and 82.5 nM for VEGFR-1, VEGFR-2, VEGFR-3, FGFR-1 and FGFR-2, respectively.
More Information Supplier PageE-3810 is a potent and selective dual inhibitor of VEGF and FGF receptors with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM and 82.5 nM for VEGFR-1, VEGFR-2, VEGFR-3, FGFR-1 and FGFR-2, respectively.
More Information Supplier PageE-4031 dihydrochloride is a selective blocker of KV11.1 (hERG) channels; inhibits the rapid delayed-rectifier K+ current (IKr).
More Information Supplier PageE-4031 dihydrochloride is a selective blocker of KV11.1 (hERG) channels; inhibits the rapid delayed-rectifier K+ current (IKr).
More Information Supplier PageE-4031 dihydrochloride is a selective blocker of KV11.1 (hERG) channels; inhibits the rapid delayed-rectifier K+ current (IKr).
More Information Supplier PageE-4031 dihydrochloride is a selective blocker of KV11.1 (hERG) channels; inhibits the rapid delayed-rectifier K+ current (IKr).
More Information Supplier PageE-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageE-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageE-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageE-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageE7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.
More Information Supplier PageE7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.
More Information Supplier PageE7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.
More Information Supplier PageE7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.
More Information Supplier PageE7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.
More Information Supplier PageE3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
More Information Supplier PageE3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
More Information Supplier PageE3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
More Information Supplier PageE7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
More Information Supplier PageE7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
More Information Supplier PageE7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
More Information Supplier PageE7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
More Information Supplier PageE7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
More Information Supplier PageE7820 is a small molecule and aromatic sulfonamide derivative with potential antiangiogenic and antitumor activities. E7820 inhibits angiogenesis by suppressing integrin alpha 2, a cell adhesion molecule expressed on endothelial cells.
More Information Supplier PageE7820 is a small molecule and aromatic sulfonamide derivative with potential antiangiogenic and antitumor activities. E7820 inhibits angiogenesis by suppressing integrin alpha 2, a cell adhesion molecule expressed on endothelial cells.
More Information Supplier PageE7820 is a small molecule and aromatic sulfonamide derivative with potential antiangiogenic and antitumor activities. E7820 inhibits angiogenesis by suppressing integrin alpha 2, a cell adhesion molecule expressed on endothelial cells.
More Information Supplier PageEbastine is a H1 antihistamine with low potential for causing drowsiness.
More Information Supplier PageEbastine is a H1 antihistamine with low potential for causing drowsiness.
More Information Supplier PageEBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
More Information Supplier Page
